Prostate Cancer impact factor, indexing, ranking (2024)


prostate

Aim and Scope

The Prostate Cancer is a research journal that publishes research in the field of Oncology. This journal is published by the HINDAWI LTD. The ISSN of this journal is 2090-3111.

Also, please check the following important details about prostate cancer: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.

Important Metrics

Journal Title: PROSTATE CANCER
Publisher: HINDAWI LTD
ISSN: 2090-3111
E-ISSN: 2090-312X
Language: English
Country of Publisher: ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, ENGLAND, W1T 5HF
Subject: Oncology

prostate cancer Indexing

The prostate cancer is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Prostate Cancer?

If your research is related to Oncology, then visit the official website of prostate cancer and send your manuscript.

Tips for publishing in Prostate Cancer:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.


Final Summary

  • It is published by HINDAWI LTD.
  • The journal is indexed in UGC CARE, ESCI.









SIMILIAR JOURNALS


ADVANCES IN CANCER BIOLOGY-METASTASIS

ISSN:
Publisher: ELSEVIER

ADVANCES IN RADIATION ONCOLOGY

ISSN:
Publisher: ELSEVIER INC

BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY

ISSN: 1179-9889
Publisher: DOVE MEDICAL PRESS LTD

BLOOD CANCER DISCOVERY

ISSN: 2643-3230
Publisher: AMER ASSOC CANCER RESEARCH

BREAST CANCER-BASIC AND CLINICAL RESEARCH

ISSN: 1178-2234
Publisher: SAGE PUBLICATIONS LTD

BREAST CANCER MANAGEMENT

ISSN: 1758-1923
Publisher: FUTURE MEDICINE LTD

CANCER DRUG RESISTANCE

ISSN:
Publisher: OAE PUBLISHING INC

CANCER INFORMATICS

ISSN:
Publisher: SAGE PUBLICATIONS LTD

CANCER REPORTS

ISSN:
Publisher: WILEY

CANCER RESEARCH COMMUNICATIONS

ISSN:
Publisher: AMER ASSOC CANCER RESEARCH

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.